Evidence map›Paper›PMID 39766805›Full record

ArticleGenes2024

Comprehensive Analysis Reveals That ISCA1 Is Correlated with Ferroptosis-Related Genes Across Cancers and Is a Biomarker in Thyroid Carcinoma.

Dejun Xiong, Zhao Li, Ling Zuo, Juan Ge, Yuhan Gu, Erhao Zhang, Xiaorong Zhou, Guiping Yu, Mengmeng Sang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Genes, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Dejun XiongDepartment of Immunology, School of Medicine, Nantong University, Nantong 226019, China.
Zhao LiDepartment of Immunology, School of Medicine, Nantong University, Nantong 226019, China.
Ling ZuoDepartment of Immunology, School of Medicine, Nantong University, Nantong 226019, China.
Juan GeDepartment of Immunology, School of Medicine, Nantong University, Nantong 226019, China.
Yuhan GuDepartment of Immunology, School of Medicine, Nantong University, Nantong 226019, China.
Erhao ZhangDepartment of Immunology, School of Medicine, Nantong University, Nantong 226019, China.
Xiaorong ZhouDepartment of Immunology, School of Medicine, Nantong University, Nantong 226019, China.ORCID 0000-0002-6120-7318
Guiping YuDepartment of Cardiothoracic Surgery, Jiangyin People's Hospital Affiliated to Nantong University, Jiangyin 214499, China.
Mengmeng SangDepartment of Immunology, School of Medicine, Nantong University, Nantong 226019, China.

Funding

Jiangsu Province Capability Improvement Project through Science, Technology and Education ZDXK202234Jiangsu Provincial Research Hospital YJXYY202204National Natural Science Foundation of China 32170915National Natural Science Foundation of China 82172931
6 · The paper itself

Abstract

background

methodsIn this study, we analyzed the expression and prognosis of

resultsWe performed drug prediction and validation through molecular docking and molecular dynamics analysis to identify candidate drugs that could promote or inhibit

conclusionsOverall, our study highlights the potential of

Indexed as

Biomarkers, TumorFerroptosisGene Expression Regulation, NeoplasticThyroid NeoplasmsHumansIron-Sulfur ProteinsPrognosisTumor MicroenvironmentBiomarkers, TumorIron-Sulfur Proteinsdrug predictionferroptosis-related genesISCA1pan-cancerthyroid carcinoma

Identifiers

PMID39766805
PMCPMC11675480

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.